Related Experiment Videos
Generation of transgenic mice expressing human hemoglobin E.
Qiuying Chen1, Eric E Bouhassira, Arnaud Besse
1Department of Medicine/Hematology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Blood Cells, Molecules & Diseases
|November 6, 2004
Summary
Researchers created transgenic mice to model Hemoglobin E (HbE) related diseases. These mice show red blood cell changes similar to human HbE trait, aiding future disease research.
Area of Science:
- Genetics
- Hematology
- Animal Models
Background:
- Hemoglobin E (HbE) is a prevalent abnormal hemoglobin variant globally, particularly in Southeast Asia.
- HbE is the third most common variant in the US, with increasing frequency due to immigration.
- While HbE homozygotes are typically asymptomatic, co-inheritance with beta0-thalassemia or HbS causes severe hemoglobinopathies.
Purpose of the Study:
- To develop the first transgenic animal model for Hemoglobin E (HbE)-related diseases.
- To create mice expressing human HbE to study its effects in vivo.
- To establish a platform for investigating HbE pathophysiology and potential therapeutic strategies.
Main Methods:
- Generation of transgenic mice carrying the human HbE gene.
- Phenotypic analysis of red blood cells in the betaE mice.
- Biochemical analysis of hemolysates from transgenic mice.
Main Results:
- Transgenic mice (betaE mice) exhibit red blood cell hypochromia and target cells, mirroring human HbE trait.
- Analysis revealed increased levels of hemoglobin oxidation products in the hemolysates of betaE mice.
- The developed mouse model successfully recapitulates key hematological features of HbE.
Conclusions:
- The creation of transgenic HbE mice provides a valuable animal model for studying HbE-related disorders.
- This model will facilitate research into the mechanisms underlying HbE pathophysiology.
- Further studies using these mice can aid in the development of treatments for HbE-associated hemoglobinopathies.